- $423.23m
- $146.11m
- $4.66m
PureTech Health PLC Citigroup Inc - Holding(s) in Company
PureTech Health PLC Citigroup Inc - Holding(s) in Company
PureTech Health PLC Citigroup Inc - Holding(s) in Company
Holding(s) in Company
Brief: Puretech Presents New Data From Phase 2b Open-Label Extension Study Of Deupirfenidone
PRTC: New IPF Data Show Switch Patients Stabilized
Pdmr Dealing: PURCHASE OF SHARES
Holding(s) in Company
PureTech Health PLC Citigroup Inc - Holding(s) in Company
Holding(s) in Company
Brief: PureTech Health's Seaport Therapeutics Begins Phase 1 Trial of GlyphAgo; Advances Second Clinical Candidate
PRTC's Seaport Advances 2nd Candidate Into Clinic
Holding(s) in Company
Half-year Report
PureTech Showcases Differentiated IPF Strategy
Notice of Results
Brief: PureTech Founded Vedanta Biosciences Announces Phase 2 Study Of Ve202 Did Not Meet Primary Endpoint
PRTC's Vedanta Announces VE202 Phase 2 Results
Brief: Puretech Health Launches Celea Therapeutics For Respiratory Diseases